...
首页> 外文期刊>British journal of ophthalmology >Initial therapy for suppurative microbial keratitis in Iraq.
【24h】

Initial therapy for suppurative microbial keratitis in Iraq.

机译:化脓性微生物性角膜炎在伊拉克的初步治疗。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To provide data-based guidelines for selection of an appropriate initial therapy for management suppurative microbial keratitis (SMK) in Iraq. METHODS: This case-series study enrolled patients with clinical signs of suppurative keratitis suspected of being microbial, presented prospectively at Ibn Al-Haetham Teaching Eye Hospital from April 2002 to March 2005. Predisposing factors, microbial profile and sensitivities of isolated bacteria were determined. If direct microscopic examination of smears was negative for fungal elements, initial therapy started with ciprofloxacin 0.3% eye-drops. Subsequent treatment depends on clinical response and cultures' results. RESULTS: Out of 396 cases enrolled, positive cultures were obtained in 232 cases (58.6%). The predominating agents isolated were Gram-positive cocci (Staphylococcus and Streptococcus) 75 cases (18.9%); Pseudomonas 68 cases (17.2%); and fungal species 74 cases (18.7%). Treatment was initiated with ciprofloxacin eye-drops in 364 cases, afavourable response was recorded in 185 cases (50.8%), addition of other antimicrobial drugs was required in 56 cases (15.4%), while failure of treatment was recorded in 123 cases (33.8%). CONCLUSION: Use of ciprofloxacin eye drops alone as an initial therapy cannot cover most of the causative agents of SMK in Iraq. Addition of another drug can provide a better coverage for the predominating causative agents. The choice of this additional drug is based on the suspected infecting agent depending on the regional predisposing factors, and the clinical features.
机译:目的:为选择治疗伊拉克化脓性微生物性角膜炎(SMK)的适当初始疗法提供基于数据的指南。方法:该病例系列研究招募了2002年4月至2005年3月在Ibn Al-Haetham眼科医院就诊的怀疑患有化脓性角膜炎的临床症状的患者。确定了诱发因素,微生物谱和分离细菌的敏感性。如果直接显微镜检查涂片中的真菌成分为阴性,则初始治疗应以0.3%的环丙沙星滴眼液开始。后续治疗取决于临床反应和培养结果。结果:在纳入的396例患者中,有232例获得了阳性培养(58.6%)。分离出的主要药物为革兰氏阳性球菌(葡萄球菌和链球菌)75例(18.9%);假单胞菌68例(17.2%);真菌种类74例(18.7%)。环丙沙星滴眼液治疗开始364例,有良好反应185例(50.8%),其他抗菌药物需要56例(15.4%),治疗失败123例(33.8) %)。结论:单独使用环丙沙星滴眼液作为初始治疗不能覆盖伊拉克SMK的大多数病原体。添加另一种药物可以更好地覆盖主要的病原体。根据地区的易感因素和临床特征,根据疑似感染因素选择其他药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号